About Shunichiro "Steve" Okada
Shunichiro "Steve" Okada is a chief medical officer at Invea Therapeutics.
Shunichiro "Steve" Okada first appears on SEC filings in 2022.
Experience
This experience comes from SEC filings. The years are when the filings name Shunichiro "Steve" Okada in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Shunichiro "Steve" Okada works with at each company, as listed on that company's latest Form D.
Invea Therapeutics, Inc · Form D, Dec 10, 2025
DK
Demetrios Kydonieus
Director
AK
Aman Kant
President
SA
Salvatore Alesci
Chief Scientific Officer
MA
Michael Aiello
Chief Financial Officer
JZ
Jonathan Zalevsky
Director
SD
Stephen Doberstein
Director
KB
Kerrie Brady
Director
KN
Krishnan Nandabalan
Chief Executive Officer and Chairman